The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Jagpal Sukhi since 2012.
The trader's CIK number is 1554591.
At the time of the last reporting, Jagpal Sukhi was the Interim CFO of Novelion Therapeutics Inc.. (stock ticker symbol NVLNF).
Also see all insider trading activities at Novelion Therapeutics Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2013 | QLTI | 0 | $0 | 10,000 | $79,550 | 10,000 | $71,200 |
2012 | QLTI | 0 | $0 | 67,000 | $548,730 | 67,000 | $329,506 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2013-05-14 | QLTI | Sale | 10,000 | 7.96 | 79,550 |
2013-05-14 | QLTI | Option Ex | 10,000 | 7.12 | 71,200 |
2012-08-03 | QLTI | Sale | 67,000 | 8.19 | 548,730 |
2012-08-03 | QLTI | Option Ex | 67,000 | 4.92 | 329,506 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jagpal Sukhi (Interim CFO of Novelion Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.